Pfizer in talks with India over expedited approval for Covid 19
We Care...!!!

NEW DELHI: Pfizer is in discussions with the Indian authorities searching for an “expedited approval pathway” for its Covid-19 vaccine, its CEO Albert Bourla stated on LinkedIn on Monday, asserting a donation of medicines price greater than $70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he stated.
“We are at the moment discussing with the Indian authorities an expedited approval pathway to make our Pfizer-BioNTech vaccine accessible to be used within the nation.”


Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »